Regulatory Filings • Jul 29, 2025
Regulatory Filings
Open in ViewerOpens in native device viewer
_________ false
| ��-���� ������� ��"� | 2 381 |
| CAN-FITE BIOPHARMA LTD | |
| Corporation no: 512022153 | 14960 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 29/07/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-056431 | Time of broadcast: 17:02 17:02 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | 424B4: Prospectus Filed pursuant to Rule 424(b)(4) |
ea025050001-424b4_canfiteEDGAR5_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| 2025-02-056142 | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 06/08/2024 |
| Address: Bareket 10 , Petach-Tikva 47190 , Tel: 03-9241114 , 03-9213501 Fax: 03-9249378 | |
| E-mail address: [email protected] Company site: www.canfite.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: FARBSTEIN MORDECHAI Position of Signatory in the reporting corporation: Chief Operating Officer & CFO Name of Employer Company: | |
| Address: Maharal street 10 , Tel Aviv 6248110 Telephone: 052-8998671 Facsimile: E-mail: [email protected] 1 | |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.